Dallah Healthcare Company (TADAWUL:4004)

Market Cap	13.38B
Revenue (ttm)	3.55B
Net Income (ttm)	519.88M
Shares Out	101.20M
EPS (ttm)	5.28
PE Ratio	25.03
Forward PE	22.98
Dividend	2.00 (1.51%)
Ex-Dividend Date	Aug 18, 2025

Volume	77,971
Average Volume	48,068
Open	132.00
Previous Close	132.20
Day's Range	131.60 - 133.80
52-Week Range	109.00 - 169.20
Beta	0.05
RSI	50.78
Earnings Date	Aug 11, 2025

About Dallah Healthcare Company

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was for...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1987
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4004

Financial Performance

In 2024, Dallah Healthcare Company's revenue was 3.21 billion, an increase of 8.93% compared to the previous year's 2.94 billion. Earnings were 471.20 million, an increase of 30.84%.